Download Citation
Article Source:
Inhibition of PI3K/mTOR Overcomes Nilotinib Resistance in BCR-ABL1 Positive Leukemia Cells through Translational Down-Regulation of MDM2
Ding J,
Romani J,
Zaborski M,
MacLeod RAF,
Nagel S,
et al.
(2013)
Inhibition of PI3K/mTOR Overcomes Nilotinib Resistance in BCR-ABL1 Positive Leukemia Cells through Translational Down-Regulation of MDM2.
PLOS ONE 8(12): e83510.
https://doi.org/10.1371/journal.pone.0083510